P41182 (BCL6_HUMAN) Homo sapiens (Human)
B-cell lymphoma 6 protein UniProtKBInterProSTRINGInteractive Modelling
706 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
108 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the BCL6 BTB domain complexed with a SMRT co-repressor peptide |
Heteromer Q9Y618; | 97.6 | ||||
| Crystal structure of the BCL6 BTB domain dimer in complex with the BCOR BBD corepressor peptide |
Heteromer Q6W2J9; | 97.6 | ||||
| Crystal structure of an NCoR1BBD2-BCL6BTB chimera in complex with the NcoR1 BBD1 corepressor peptide |
Heteromer O75376; | 97.56 | 28×SO4; 4×GOL; | |||
| Crystal structure of the BCL6 BTB domain in complex with the NCoR1 BBD2 peptide |
Heteromer O75376; | 97.56 | 14×NA; 4×CL; 2×TFA; | |||
| Crystal structure of an NCoR1BBD2-BCL6BTB chimera in complex with nebulinSH3-NCoR1BBD1 |
Heteromer O75376; P20929; | 97.56 | 1×NA; | |||
| Crystal structure of the BCL6 BTB domain in complex with a hybrid BTB-binding (HBP) peptide |
Heteromer | 97.56 | 1×NA; | |||
| Crystal structure of the talin-KANK1 complex |
Heteromer O75376; P26039; Q14678; | 97.52 | 12×SO4; 3×GOL; | |||
| Crystal structure of an NCoR1BBD2-BCL6BTB chimera in complex with the NcoR1 BBD1 corepressor peptid… |
Heteromer O75376; | 97.54 | ||||
| Crystal structure of the BCL6 BTB domain in complex with the NCoR1 BBD corepressor peptide |
Heteromer O75376; | 97.5 | 2×NA; 1×EDO; | |||
| Cryo-EM structure of BCL6 bound to BI-3802 | homo-8-mer | 100 | 8×U52; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-4425 | homo-2-mer | 97.66 | 2×YJV; 2×DMS; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-7629 | homo-2-mer | 97.64 | 2×YND; 2×FMT; 4×ACT; 2×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 13e | homo-2-mer | 100 | 2×VJ5; 12×EDO; 6×CL; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 8e | homo-2-mer | 100 | 2×VHB; 10×EDO; 4×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 19 | homo-2-mer | 100 | 2×KA0; 8×EDO; 2×CL; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 2 | homo-2-mer | 100 | 2×KCB; 10×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 22 | homo-2-mer | 100 | 2×K6I; 8×EDO; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 12c and its enantiomer 12b | homo-2-mer | 100 | 2×VHN; 2×VHZ; 12×EDO; 4×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 23d | homo-2-mer | 100 | 2×NQT; 24×EDO; 8×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 4 | homo-2-mer | 100 | 2×97S; 10×EDO; 4×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 7 | homo-2-mer | 100 | 2×9FW; 10×EDO; 2×DMS; 2×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 13g | homo-2-mer | 100 | 2×VJ2; 12×EDO; 2×DMS; 2×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 2 | homo-2-mer | 100 | 2×VHQ; 14×EDO; 2×CL; 4×DMS; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-12387 | homo-2-mer | 97.54 | 1×SO4; 1×GOL; 2×CL; 2×E3I; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 11a | homo-2-mer | 100 | 2×NR8; 6×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 13 | homo-2-mer | 100 | 2×K5I; 8×EDO; 2×DMS; 2×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 15 | homo-2-mer | 100 | 2×K8R; 14×EDO; 2×CL; 4×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 11f | homo-2-mer | 100 | 2×NQN; 10×EDO; 4×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 8c | homo-2-mer | 100 | 2×VH5; 12×EDO; 6×DMS; 4×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 12b | homo-2-mer | 100 | 2×VHZ; 6×EDO; 4×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 25a | homo-2-mer | 100 | 2×NQW; 16×EDO; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 10 | homo-2-mer | 100 | 4×K4O; 18×EDO; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 21 | homo-2-mer | 100 | 2×K6R; 2×EDO; 2×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 18 | homo-2-mer | 100 | 2×K69; 4×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 1 | homo-2-mer | 100 | 2×9IH; 2×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 9a | homo-2-mer | 100 | 2×9IE; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound CCT374705 | homo-2-mer | 100 | 2×TWI; 8×EDO; 4×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 12a | homo-2-mer | 100 | 2×9GR; 4×EDO; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 17a | homo-2-mer | 100 | 2×NQQ; 8×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 7 | homo-2-mer | 100 | 2×K4C; 4×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 1 | homo-2-mer | 100 | 2×NQZ; 6×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 14 | homo-2-mer | 100 | 2×K5U; 2×CL; 4×EDO; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 25 | homo-2-mer | 100 | 2×VGW; 6×EDO; 4×DMS; | |||
| Crystal structure of the BCL6 BTB domain in complex with F1324(10-13) | homo-2-mer | 100 | 2×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 12a | homo-2-mer | 100 | 2×EBL; 2×CL; 4×EDO; 4×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 25b | homo-2-mer | 100 | 2×NR5; 4×EDO; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-10256 | homo-2-mer | 97.56 | 2×SO4; 2×GOL; 3×CL; 2×YJJ; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 11 | homo-2-mer | 100 | 2×K4X; 16×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 8f | homo-2-mer | 100 | 2×VHK; 12×EDO; 2×CL; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 17 | homo-2-mer | 100 | 2×KA9; 18×EDO; 4×GOL; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 6 | homo-2-mer | 100 | 2×NQK; 8×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 4 | homo-2-mer | 100 | 2×NQE; 8×EDO; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 5 | homo-2-mer | 100 | 2×NQH; 2×DMS; 2×CL; | |||
| HUMAN BCL6 BTB-DOMAIN IN COMPLEX WITH GSK137 | homo-2-mer | 97.58 | 2×TEQ; 2×GOL; 2×DMS; | |||
| Crystal structure of human BCL6 BTB domain in complex with a WVIP peptide | homo-2-mer | 100 | 8×EDO; 4×DMS; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-8826 | homo-2-mer | 97.56 | 2×7RH; 4×SO4; 2×DMS; | |||
| Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine ligand | homo-2-mer | 97.56 | 2×8GN; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-9322 | homo-2-mer | 97.56 | 2×7SH; 4×GOL; 2×CA; | |||
| Crystal structure of the BCL6 BTB domain in complex with an Apt48 peptide | homo-2-mer | 97.56 | 5×CL; 2×MG; 1×GOL; 1×NA; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-9288 | homo-2-mer | 97.56 | 2×7SC; 2×DMS; 2×GOL; | |||
| BCL6 BTB domain in complex with 15a | homo-2-mer | 96.75 | 2×F8J; | |||
| Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine macrocyclic ligand | homo-2-mer | 97.56 | 2×CL; 2×8GQ; | |||
| Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligand | homo-2-mer | 97.56 | 2×CL; 2×C0Q; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-10562 | homo-2-mer | 97.56 | 1×DMS; 2×E1I; | |||
| Crystal structure of human BCL6 BTB domain in complex with compound 12e | homo-2-mer | 100 | 2×VH8; 6×EDO; 2×CL; | |||
| Crystal Structure of the Wild-Type Human BCL6 BTB/POZ Domain | homo-2-mer | 100.0 | ||||
| Crystal structure of BCL6 BTB domain in complex with compound 7CC5 | homo-2-mer | 96.75 | 2×EHY; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-9320 | homo-2-mer | 97.54 | 2×YNA; 2×GOL; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-10268 | homo-2-mer | 97.54 | 2×7ST; 2×DMS; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-9153 | homo-2-mer | 97.54 | 2×7SO; 2×DMS; 4×SO4; 4×CL; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-8388 | homo-2-mer | 97.54 | 2×7S0; 8×FMT; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-8828 | homo-2-mer | 97.54 | 2×828; 2×DMS; 6×SO4; 2×CL; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-12694 | homo-2-mer | 97.54 | 2×YN7; 2×GOL; 4×UNX; | |||
| Crystal Structure of the B-Cell Lymphoma 6 (BCL6) BTB Domain to 1.3 Angstrom | homo-2-mer | 97.54 | ||||
| Crystal structure of the BCL6 BTB domain in complex with OICR-7859 | homo-2-mer | 97.54 | 2×7RR; 6×FMT; 2×CL; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-8311 | homo-2-mer | 97.54 | 2×7RW; 6×FMT; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-9124 | homo-2-mer | 97.54 | 2×7R5; 4×SO4; 2×CL; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-8446 | homo-2-mer | 97.54 | 2×7RL; 8×FMT; 2×CL; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-11029 | homo-2-mer | 97.54 | 2×YJS; 2×DMS; 2×SO4; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-10269 | homo-2-mer | 97.54 | 2×7SZ; 2×DMS; | |||
| Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligand | homo-2-mer | 97.54 | 2×CL; 2×C1W; | |||
| Crystal structure of an NCoR1BBD2-BCL6BTB chimera | homo-2-mer | 97.54 | 2×MPD; 2×CL; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-8445 | homo-2-mer | 97.54 | 2×7S5; 8×FMT; 2×CL; | |||
| Crystal structure of the BCL6 BTB-domain with compound 1 | homo-2-mer | 97.54 | 2×RC0; | |||
| Crystal structure of the BCL6 BTB-domain with compound 2 | homo-2-mer | 97.54 | 2×TJ3; | |||
| Crystal structure of the BCL6 BTB domain in complex with F1324 | homo-2-mer | 100 | 2×SO4; | |||
| Crystal structure of the BCL6 BTB domain in complex with OICR-11864 | homo-2-mer | 97.54 | 2×E2E; 2×GOL; 2×CL; | |||
| Crystal Structure of the B-Cell Lymphoma 6 (BCL6) BTB domain to 2.2 Angstrom | homo-2-mer | 97.54 | ||||
| Crystal structure of the BCL6 BTB domain in complex with OICR-9287 | homo-2-mer | 97.54 | 2×7RB; | |||
| Crystal Structure of the BCL6 BTB domain complexed with the small molecule inhibitor 79-6 | homo-2-mer | 97.54 | 2×Z88; 3×Z89; | |||
| CRYSTAL STRUCTURE OF BCL-6 BTB-domain with BI-3802 | homo-2-mer | 97.54 | 2×U52; | |||
| The structure of BCL6 BTB (POZ) domain in complex with the ansamycin antibiotic rifabutin. | homo-2-mer | 98.32 | 1×RBT; | |||
| Crystal structure of the BCL6 BTB domain in complex with Compound 1a | monomer | 100 | 1×80R; 1×EDO; 1×K; | |||
| Crystal structure of the BCL6 BTB domain in complex with Compound 1 | monomer | 100 | 1×7ZF; | |||
| Crystal structure of the BCL6 BTB domain in complex with Compound 5 | monomer | 100 | 1×80L; | |||
| Crystal structure of the BCL6 BTB domain in complex with Compound 4 | monomer | 100 | 1×7ZL; 1×EDO; | |||
| Crystal structure of the BCL6 BTB domain in complex with Compound 7 | monomer | 100 | 1×7Z6; 1×EDO; 1×K; | |||
| Crystal structure of the BCL6 BTB domain in complex with Compound 5 | monomer | 100 | 1×YAM; | |||
| Crystal structure of the BCL6 BTB domain in complex with Compound 6 | monomer | 100 | 1×7ZO; | |||
| Crystal structure of BCL6 BTB domain with compound 15f | monomer | 96.77 | 1×EGP; | |||
| Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligand | monomer | 96.75 | 1×C0H; | |||
| Crystal structure of a complex of the Miz1- and BCL6 POZ domains. | monomer | 100 | ||||
| Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine ligand | monomer | 97.54 | 1×CL; 1×8HN; | |||
| Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine ligand | monomer | 97.5 | ||||
| Chemical shift assignment of Hr4436B from Homo Sapiens, Northeast Structural Genomics Consortium | monomer | 100 | 2×ZN; | |||
| Solution structure of the 1st zf-C2H2 domain from Human B-cell lymphoma 6 protein | monomer | 100 | 1×ZN; | |||
| Solution structure of the C2H2 type zinc finger (region 626-654) of human B-cell lymphoma 6 protein | monomer | 100 | 1×ZN; | |||
| Solution structure of the C2H2 type zinc finger (region 598-626) of human B-cell lymphoma 6 protein | monomer | 100 | 1×ZN; | |||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6xmx.1.A | monomer | 0.75 | 99.72 | |||
| 5v3j.2.C | monomer | 0.54 | 4×ZN; | 32.39 | ||
| 5v3j.2.C | monomer | 0.54 | 4×ZN; 1×MG; | 34.11 | ||
| 8ssq.2.A | monomer | 0.50 | 2×ZN; | 29.80 | ||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6xmx.1.A | monomer | 0.77 | 99.72 | |||
| Isoform 2 | 5v3g.1.F | monomer | 0.52 | 3×ZN; | 45.39 | ||